Smurfit Kappa Group Operating Cash Flow decreased by 82.9% to $204.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.2%, from $235.00M to $204.00M. Over 3 years (FY 2022 to FY 2025), Operating Cash Flow shows an upward trend with a 33.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $358.25M | $358.25M | $358.25M | $358.25M | $0.00 | $0.00 | $948.00M | $611.00M | $42.00M | $340.00M | $320.00M | $781.00M | $235.00M | $829.00M | $1.13B | $1.20B | $204.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | -35.5% | -93.1% | +709.5% | -5.9% | +144.1% | -69.9% | +252.8% | +36.7% | +5.5% | -82.9% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | +164.6% | +70.6% | — | — | -66.2% | +27.8% | +459.5% | +143.8% | +254.1% | +53.0% | -13.2% |